ITEM 7.01. REGULATION FD DISCLOSURE.

On December 6, 2012, the Company issued a press release entitled "Positive Data from Independent Study of Chembio Diagnostics' Rapid, Point-of-Care Syphilis Test Published in Clinical Infectious Diseases". A copy of the press release is furnished herewith as Exhibit 99.1.

The information in this Item 7.01 of this Form 8-K is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section. The information in this Item 7.01 of this Form 8-K also shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

Exhibits.

99.1 Press Release entitled "Positive Data from Independent Study of Chembio Diagnostics' Rapid, Point-of-Care Syphilis Test Published in Clinical Infectious Diseases" dated December 6, 2012.

---